2019
DOI: 10.1007/s13577-018-00225-1
|View full text |Cite
|
Sign up to set email alerts
|

Suppression of miR-93-5p inhibits high-risk HPV-positive cervical cancer progression via targeting of BTG3

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
16
1
1

Year Published

2019
2019
2022
2022

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 22 publications
(20 citation statements)
references
References 38 publications
2
16
1
1
Order By: Relevance
“…The results indicated that in SW480 cells, miR‐93‐5p regulated PD‐L1 specifically and negatively, which was previously found in pancreatic cancer (Cioffi et al, 2017); moreover, we also noted that transfection of miR‐93‐5p mimics decreased the level of PD‐L1, and this effect was abolished with the administration of inhibitors; in PD‐L1‐negative patients, miR‐93‐5p expression was significantly elevated, suggesting the key role of miR‐93‐5p targeting PD‐L1 . miR‐93‐5p, a member of the miR‐106b‐25 gene cluster located on chromosome 7q22, is not only an oncogene in many tumors (Li et al, 2018, 2019) but is also a tumor suppressor in certain tumors (Shyamasundar et al, 2016; Xiang et al, 2017). The results of this study suggested that miR‐93‐5p expression was downregulated in the tumor tissues and had a significant association with the major clinicopathological features and survival of patients.…”
Section: Discussionmentioning
confidence: 99%
“…The results indicated that in SW480 cells, miR‐93‐5p regulated PD‐L1 specifically and negatively, which was previously found in pancreatic cancer (Cioffi et al, 2017); moreover, we also noted that transfection of miR‐93‐5p mimics decreased the level of PD‐L1, and this effect was abolished with the administration of inhibitors; in PD‐L1‐negative patients, miR‐93‐5p expression was significantly elevated, suggesting the key role of miR‐93‐5p targeting PD‐L1 . miR‐93‐5p, a member of the miR‐106b‐25 gene cluster located on chromosome 7q22, is not only an oncogene in many tumors (Li et al, 2018, 2019) but is also a tumor suppressor in certain tumors (Shyamasundar et al, 2016; Xiang et al, 2017). The results of this study suggested that miR‐93‐5p expression was downregulated in the tumor tissues and had a significant association with the major clinicopathological features and survival of patients.…”
Section: Discussionmentioning
confidence: 99%
“…12 These studies suggest that the abnormal expression of miRNAs may affect the malignant progression of CC. It has been reported that miR-145-5p is down-regulated in a variety of human cancers, such as breast cancer 13 and bladder cancer 14 , and plays an inhibitory role in tumor growth. In addition, miR-145 has been confirmed to have the potential serving as a candidate biomarker for human diagnosis.…”
Section: Introductionmentioning
confidence: 99%
“…3 The symptoms of CC normally occur at the advanced stage, leading to the vitiation of the optimum treatment time and high mortality, particularly in developing countries. 4,5 In addition, smoking, age, race and secondary malignancies caused by invasiveness are critical risk factors of poor prognosis. 6 Therefore, the discovery of novel biomarkers is imperative for the therapy of CC.…”
Section: Introductionmentioning
confidence: 99%